Ovid Therapeutics Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
OVID Nasdaq 2830 www.ovidrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ovid Therapeutics Inc.

Ovid Therapeutics to Participate in Upcoming Investor Conferences - Jun 4th, 2026 5:00 am
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors - Jun 3rd, 2026 5:00 am
We're Hopeful That Ovid Therapeutics (NASDAQ:OVID) Will Use Its Cash Wisely - May 14th, 2026 4:51 am
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - May 12th, 2026 5:00 am
Here is Why Ovid Therapeutics (OVID) is One of the Best Fast Growing Penny Stocks - May 9th, 2026 10:01 pm
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 - Apr 8th, 2026 6:00 am
Ovid Therapeutics Q4 Earnings Call Highlights - Mar 18th, 2026 3:47 pm
Here's Why Ovid Therapeutics Stock Popped Higher Today - Mar 18th, 2026 12:37 pm
Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting - Mar 18th, 2026 7:28 am
Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates - Mar 18th, 2026 5:50 am
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results - Mar 18th, 2026 4:05 am
Ovid Therapeutics Announces Pricing of $60 Million Private Placement - Mar 18th, 2026 4:00 am
Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates - Mar 4th, 2026 3:35 pm
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates - Feb 19th, 2026 5:00 pm
Ovid takes another big swing in neuroscience under a new CEO - Feb 13th, 2026 1:00 am
Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts? - Jan 30th, 2026 12:58 pm
Promising Penny Stocks To Watch In December 2025 - Dec 26th, 2025 5:04 am
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV) - Dec 18th, 2025 6:00 am
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer - Dec 2nd, 2025 5:00 am
November 2025's Top Penny Stock Opportunities - Nov 27th, 2025 11:04 am